Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| Global X China Biotech Innovations ETF | CHB | NASDAQ | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 6.64 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.64 | 6.64 |
| Trades | Etfs Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 6.63 - 8.55 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | 6.64 | USD |
Global X China Biotech Innovations ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.39M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Global X China Biotech I...
| Date | Time | Source | Heading |
|---|---|---|---|
| 1/19/2024 | 15:37 | PR Newswire (US) | Global X ETFs To Liquidate 19 ETFs |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
CHB Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 7.92 | 8.1397 | 6.63 | 6.95 | 658 | -1.28 | -16.16% |
| 1 Year | 7.90 | 8.55 | 6.63 | 7.65 | 736 | -1.26 | -15.95% |
| 3 Years | 18.00 | 19.22 | 6.63 | 11.96 | 1,047 | -11.36 | -63.11% |
| 5 Years | 15.24 | 20.17 | 6.63 | 14.88 | 1,887 | -8.60 | -56.43% |
| The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index (underlying index). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified. The Fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the Solactive China Biotech Innovation Index (Underlying Index) and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the Underlying Index. |
